脊柱感染治疗评估评分的外部验证:单中心19年新发脊柱感染回顾性分析
该研究对2004年7月1日至2023年3月31日单中心194例新发脊柱感染患者进行回顾性病历审查,评估SITE评分区分手术与药物治疗的预测能力,结果显示SITE评分预测手术治疗的敏感度为68.6%、特异度为59.3%,AUC为0.66,作者认为该评分无法准确预测治疗方式,需进一步多中心研究。
要点
- SITE评分以8分为阈值预测手术治疗的敏感度为68.6%,特异度为59.3%。
- SITE评分预测手术与药物治疗的ROC曲线AUC为0.66。
- 作者认为SITE评分无法准确预测新发脊柱感染的治疗方式。
核心结论
- 在单中心新发脊柱感染队列中,SITE评分无法准确预测药物或手术治疗,作者认为需进一步多中心研究并纳入更多变量和更大队列以开发最佳预测工具。
研究设计与样本
- 回顾性病历审查,纳入2004年7月1日至2023年3月31日单中心诊断为新发脊柱感染(骨髓炎、椎间盘炎或硬膜外脓肿)的患者194例。
主要发现
- 194例患者平均年龄65.96±13.66岁,58%为男性;27%仅接受药物治疗,73%需要手术干预。
- 药物治疗组神经功能完好者占72.2%,手术组占50%(p=0.006)。
- 手术组伴或不伴畸形的椎管狭窄伴脊髓受压发生率高于非手术组(38.6% vs 22.2%,p=0.04)。
- 手术组平均SITE评分低于药物治疗组(7.16±2.39 vs 8.2±2.33,p<0.005),且多节段感染比例更高(59.3% vs 33.3%,p<0.001)。
- 以8分为阈值,SITE评分预测手术治疗的敏感度为68.6%,特异度为59.3%;ROC曲线AUC为0.66。
关键数值与推荐
- SITE评分0-8分或出现急性瘫痪或膀胱/肠道功能障碍者建议手术干预;9-12分手术干预可选;13-15分推荐药物治疗。
- 以8分为阈值预测手术治疗的敏感度为68.6%,特异度为59.3%。
- SITE评分预测手术与药物治疗的ROC曲线AUC为0.66。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The escalating incidence of de novo spinal infections poses a substantial neurological impact on patients. This has prompted a growing interest in discerning which patients would derive greater benefit from medical as opposed to surgical management of these occurrences. The authors assessed the predictive applicability of the Spinal Infection Treatment Evaluation (SITE) score in discerning between surgical intervention and medical management. This assessment represents the first external validation of the SITE score conducted in a cohort of patients with de novo spinal infections. METHODS: A comprehensive retrospective chart review was conducted to identify patients diagnosed with de novo spinal infections (osteomyelitis, discitis, or epidural abscess) at a tertiary center between July 1, 2004, and March 31, 2023. All necessary data for calculating the SITE score were collected for each patient. Surgical intervention was advised for patients scoring 0-8 or exhibiting acute plegia or bladder or bowel dysfunction and optional for those scoring 9-12; medical treatment was recommended for patients scoring 13-15. Predictability of the score was scrutinized using the area under the curve (AUC) of the receiver operating characteristic (ROC) curve. RESULTS: Among 194 identified patients, the mean ± SD age was 65.96 ± 13.66 years and 58% were men. Stratification of patients based on medical and surgical management revealed that 27% underwent medical treatment alone and 73% required surgical intervention. In the medical group, 72.2% of patients were neurologically intact compared to 50% in the surgical group (p = 0.006). Surgically managed patients exhibited a higher incidence of spinal stenosis with impingement of the spinal cord, with or without deformity, when compared to nonsurgical patients (38.6% vs 22.2%, p = 0.04). Additionally, surgically managed patients had a lower mean ± SD SITE score (7.16 ± 2.39 vs 8.2 ± 2.33, p < 0.005) and were more likely to have multilevel infection than patients who underwent medical management (59.3% vs 33.3%, p < 0.001). When patients were categorized on the basis of SITE score, the sensitivity of the score (using a threshold of 8) to predict surgical management was 68.6% and specificity was 59.3%. According to ROC curve, the SITE score exhibited an AUC of 0.66. CONCLUSIONS: Validation of the SITE score could not accurately predict medical versus surgical management in a tertiary center cohort of patients with de novo spinal infections. Further multicenter studies incorporating additional variables and larger cohorts are imperative to develop an optimal predictive tool.
引用
- Quiceno E, Soliman MAR, Khan AMA, et al. External validation of the Spinal Infection Treatment Evaluation score: a single-center 19-year review of de novo spinal infections. J Neurosurg Spine. 2024. PMID: 39642357. doi:10.3171/2024.7.SPINE24394
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。